Goullé JP, Saussereau E, Lacroix C, « Pharmacocinétique du delta-9-tétrahydrocannabinol (THC) [Delta-9-tetrahydrocannabinol pharmacokinetics] », Ann Pharm Fr, vol. 66, no 4, , p. 232-44. (PMID18847571, DOI10.1016/j.pharma.2008.07.006, résumé)modifier
(en) María Salazar, Arkaitz Carracedo, Íñigo J. Salanueva et Sonia Hernández-Tiedra, « Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells », Journal of Clinical Investigation, vol. 119, no 5, , p. 1359–1372 (ISSN0021-9738, PMID19425170, PMCIDPMC2673842, DOI10.1172/JCI37948, lire en ligne, consulté le )
(en) « Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity », Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 789, , p. 15–25 (ISSN0027-5107, DOI10.1016/j.mrfmmm.2016.05.002, lire en ligne, consulté le )
Albert Stuart Reece et Gary Kenneth Hulse, « Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development », Scientific Reports, vol. 11, (ISSN2045-2322, PMCID8260794, DOI10.1038/s41598-021-93411-5, lire en ligne, consulté le )
(en) Kenzi Riboulet-Zemouli, « ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology », Drug Science, Policy and Law, vol. 6, , p. 1–37 (ISSN2050-3245 et 2050-3245, DOI10.1177/2050324520945797, lire en ligne, consulté le )
(en) María Salazar, Arkaitz Carracedo, Íñigo J. Salanueva et Sonia Hernández-Tiedra, « Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells », Journal of Clinical Investigation, vol. 119, no 5, , p. 1359–1372 (ISSN0021-9738, PMID19425170, PMCIDPMC2673842, DOI10.1172/JCI37948, lire en ligne, consulté le )
(en) « Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity », Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 789, , p. 15–25 (ISSN0027-5107, DOI10.1016/j.mrfmmm.2016.05.002, lire en ligne, consulté le )
Albert Stuart Reece et Gary Kenneth Hulse, « Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development », Scientific Reports, vol. 11, (ISSN2045-2322, PMCID8260794, DOI10.1038/s41598-021-93411-5, lire en ligne, consulté le )
(en) Kenzi Riboulet-Zemouli, « ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology », Drug Science, Policy and Law, vol. 6, , p. 1–37 (ISSN2050-3245 et 2050-3245, DOI10.1177/2050324520945797, lire en ligne, consulté le )
jci.org
(en) María Salazar, Arkaitz Carracedo, Íñigo J. Salanueva et Sonia Hernández-Tiedra, « Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells », Journal of Clinical Investigation, vol. 119, no 5, , p. 1359–1372 (ISSN0021-9738, PMID19425170, PMCIDPMC2673842, DOI10.1172/JCI37948, lire en ligne, consulté le )
jimmunol.org
The Journal of Immunology July 1, 2000 vol. 165 no. 1 373-380Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway1, Li X. Zhu, Sherven Sharma, Marina Stolina, Brian Gardner, Michael D. Roth, Donald P. Tashkin et Steven M. Dubinett]
Goullé JP, Saussereau E, Lacroix C, « Pharmacocinétique du delta-9-tétrahydrocannabinol (THC) [Delta-9-tetrahydrocannabinol pharmacokinetics] », Ann Pharm Fr, vol. 66, no 4, , p. 232-44. (PMID18847571, DOI10.1016/j.pharma.2008.07.006, résumé)modifier
(en) Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV, « Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia », J Pain Symptom Manage, vol. 14, no 1, , p. 7-14. (PMID9223837)modifier
(en) María Salazar, Arkaitz Carracedo, Íñigo J. Salanueva et Sonia Hernández-Tiedra, « Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells », Journal of Clinical Investigation, vol. 119, no 5, , p. 1359–1372 (ISSN0021-9738, PMID19425170, PMCIDPMC2673842, DOI10.1172/JCI37948, lire en ligne, consulté le )
Albert Stuart Reece et Gary Kenneth Hulse, « Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development », Scientific Reports, vol. 11, (ISSN2045-2322, PMCID8260794, DOI10.1038/s41598-021-93411-5, lire en ligne, consulté le )
(en) Kenzi Riboulet-Zemouli, « ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology », Drug Science, Policy and Law, vol. 6, , p. 1–37 (ISSN2050-3245 et 2050-3245, DOI10.1177/2050324520945797, lire en ligne, consulté le )
Goullé JP, Saussereau E, Lacroix C, « Pharmacocinétique du delta-9-tétrahydrocannabinol (THC) [Delta-9-tetrahydrocannabinol pharmacokinetics] », Ann Pharm Fr, vol. 66, no 4, , p. 232-44. (PMID18847571, DOI10.1016/j.pharma.2008.07.006, résumé)modifier
(en) « Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity », Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 789, , p. 15–25 (ISSN0027-5107, DOI10.1016/j.mrfmmm.2016.05.002, lire en ligne, consulté le )
